Published by Josh White on 25th April 2023
(Sharecast News) - Oncology-focussed drugs and diagnostics developer Avacta reported full-year revenue of £9.7m in its preliminary results on Tuesday, up from £2.9m year-on-year.
URL: http://www.digitallook.com/dl/news/story/33458828/...